In our series of 115 metastatic breast cancer patients we have shown a similar distribution to previous studies with PTEN positivity in 69.6% of cases and loss of PTEN expression in 30.4% of cases [18,22,28,32,35,41]. Here, PTEN is linked to breast carcinoma.